Skip to content

Development of functional probiotics strain for vaginal health

Development of functional probiotics strain formula for vaginal health

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0008957
Enrollment
100
Registered
2023-11-15
Start date
2021-04-30
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Probiotic Main Ingredients: Freeze-dried Ligilactobacillus salivarius CLS0420 and Lacticaseibacillus paracasei CLPC0603 Excipients: Maltodextrin Formulation: Capsule Weight: 450 m

Sponsors

CTC Bio
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Women of childbearing aged between 19 and 50 years Voluntarily agreed to participate in this study

Exclusion criteria

Exclusion criteria: Individuals meeting any of the following criteria were excluded: 1) lack of voluntary consent 2) presence of severe vaginitis requiring immediate antibiotic treatment 3) use of antibiotics or probiotics within the past month 4) experiencing persistent vaginal bleeding 5) confirmed pregnancy

Design outcomes

Primary

MeasureTime frame
Vaginal bacterial community

Secondary

MeasureTime frame
Self-assessed health

Countries

Korea, Republic of

Contacts

Public ContactDonghyeok Seol

Seoul National University Bundang Hospital

sdh1621@snu.ac.kr+82-2-876-8820

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 5, 2026